Advertisement
Singapore markets close in 5 hours 30 minutes

  • Straits Times Index

    3,154.23
    -33.43 (-1.05%)
     

  • Nikkei

    36,818.81
    -1,260.89 (-3.31%)
     

  • Hang Seng

    16,102.81
    -283.06 (-1.73%)
     

  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     

  • Bitcoin USD

    61,898.74
    -145.76 (-0.23%)
     

  • CMC Crypto 200

    1,271.06
    +385.52 (+41.64%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • Dow

    37,775.38
    +22.07 (+0.06%)
     

  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     

  • Gold

    2,401.10
    +3.10 (+0.13%)
     

  • Crude Oil

    84.76
    +2.03 (+2.45%)
     

  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     

  • FTSE Bursa Malaysia

    1,549.69
    +4.93 (+0.32%)
     

  • Jakarta Composite Index

    7,051.05
    -115.76 (-1.62%)
     

  • PSE Index

    6,434.64
    -88.55 (-1.36%)
     

Shire buys Meritage Pharma for at least $70 million

Reuters
Vitamins made by Shire are displayed at a chemist's in northwest London July 11, 2014. REUTERS/Suzanne Plunkett

LONDON (Reuters) - Dublin-based drugmaker Shire (SHP.L) said on Tuesday it had bought U.S. firm Meritage Pharma for at least $70 million (45 million pounds), boosting its gastrointestinal drugs business.

Shire said it had obtained rights to buy privately-held Meritage in connection with its $4.2 billion acquisition of rare disease specialist Viropharma in 2014. The fee could rise if development and regulatory milestones are reached, it said.

The deal comes after Valeant Pharmaceuticals International (VRX.TO) sealed a $10.1 billion acquisition of gastrointestinal drugmaker Salix Pharmaceuticals (SLXP.O) on Sunday, and said this week it planned to strike further smaller deals.

Shire had taken initial steps to acquire Salix and was working with advisers on a potential offer, according to people familiar with the matter.

Shares in Shire were down 0.4 percent at 5170 pence at 1232 GMT.

(Reporting by Neil Maidment; Editing by Greg Mahlich)